Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Navigating the crypto market is easier with user-friendly investment approaches. This guide provides strategies designed for beginners.
21,210 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A high-profile brand deal involving Tyson Fury’s 8-Year-Old Daughter shines a light on how families can navigate inco...
A momentum ETF continues to outperform the S&P 500 over a multi-year window as markets head into 2026. Analysts weigh...
AI demand is driving a surge in data-center energy use, and space won’t be a quick fix. This report explains why runn...
Trilogy Metals has fallen hard this week, leaving investors asking whether the downturn is a short-lived pullback or ...
CrowdStrike has pulled back from recent highs. Before March 3 earnings, investors wonder if a dip offers a real buyin...
The Supreme Court ruled that broad emergency tariffs under IEEPA were unlawful, a decision that curbs presidential po...
A mid‑sized fund just boosted its stake in ServiceTitan after a sharp share drop. This article unpacks what the move ...
Nearly 40% of Stanford undergraduates are registered with disability services, a surge linked to broader Gen Z trends...
When a bank’s CEO retiires and a director sells shares, investors take notice. This article breaks down what that mov...
A Supreme Court ruling blocks Trump’s emergency tariffs, leaving executives silent as refunds, labor concerns, and ma...
The record between corporate profits and worker pay has widened to a postwar high, signaling a troubling drift in the...